Manulife (Manufacturers Life Insurance)’s Carisma Therapeutics CARM Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CARM Stock Details CARM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,059	Closed	-$46.8K	–	2969
2023 Q3	$46.8K	Hold	11,059	–	–	﹤0.01%	2945
2023 Q2	$97K	Buy	+11,059	New	+$60.2K	﹤0.01%	2858
2022 Q1	–	Sell	-1,329	Closed	-$22	–	3085
2021 Q4	$22	Buy	+1,329	New	+$26.8K	﹤0.01%	3104
2021 Q3	–	Sell	-4,947	Closed	-$457K	–	3156
2021 Q2	$457K	Buy	+4,947	New	+$315K	﹤0.01%	2500
2014 Q4	–	Sell	-57	Closed	-$13	–	3946
2014 Q3	$13	Buy	+57	New	+$13.5K	﹤0.01%	3482

Other funds holding CARM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TOTUOP

Trustees of The University of Pennsylvania Philaldelphia, Pennsylvania $104M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CARM Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Carisma Therapeutics (CARM) in Q4 2023, closing a stake of 11,059 shares — an estimated $46.8K sold.

Manulife (Manufacturers Life Insurance) first reported a position in CARM in Q3 2014 and held it in 5 quarters. The position peaked at $457K in Q2 2021. 50 funds tracked by Wall St. Rank hold CARM as of Q4 2023.

Manulife (Manufacturers Life Insurance) reported no remaining Carisma Therapeutics position as of Q4 2023 after selling out during the quarter.
Manulife (Manufacturers Life Insurance) sold 11,059 Carisma Therapeutics shares in Q4 2023, an estimated $46.8K.
Manulife (Manufacturers Life Insurance) first reported a position in Carisma Therapeutics in Q3 2014 and held it in 5 quarters.
Manulife (Manufacturers Life Insurance)'s Carisma Therapeutics position peaked at $457K in Q2 2021.
50 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.